AI-native healthcare finance startup Translucent completes $27M Series A round

iconChainthink
Share
Share IconShare IconShare IconShare IconShare IconShare IconCopy
AI summary iconSummary

expand icon
AI and crypto news outlet Chainthink has spun off Translucent, a healthcare finance startup that recently closed a $27 million Series A round led by GV, with NEA, FPV Ventures, and Virtue also participating. The company had previously raised $7 million in seed funding in August 2024. Translucent uses AI to build financial agents for hospitals, enabling real-time monitoring of multi-system data and providing decision support. The healthcare sector frequently faces challenges such as delayed financial data and complex workflows, which the platform aims to address. Volatility in inflation data has increased demand for efficient financial tools in the sector.

ChainThink reports that on March 11, according to Fortune, AI-native healthcare finance startup Translucent has raised $27 million in its Series A round, led by GV, with participation from NEA, FPV Ventures, and Virtue. Translucent previously raised $7 million in its seed round in August 2024.


Translucent is dedicated to providing hospitals with AI-driven financial agents that monitor data across multiple systems in real time and generate actionable recommendations to address common challenges in the healthcare industry, such as delayed financial data and cumbersome processes.

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.